Sumitomo Dainippon | 4506 - Ebitda

Aktienkurs
2,164.50
Täglich Wechseln
133.50 6.57%
Monatlich
-10.61%
Jährlich
189.76%
Q1 Prognose
1,942.04




Ebitda Veränderung Datum
Astellas Pharma JPY 183.68B 31.98B 2025-12
Chugai Pharma JPY 169.01B 12.52B 2025-12
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eisai JPY 30.1B 6.62B 2025-12
Kyowa Hakko Kirin JPY 45.74B 13.46B 2025-12
M3 JPY 30.4B 14.73B 2025-12
Otsuka Holdings JPY 99.77B 94.02B 2025-12
Shionogi JPY 80B 35.17B 2025-12
Sumitomo JPY 151.83B 12.02B 2025-12
Sumitomo Dainippon JPY 80.4B 54.16B 2025-09
Takeda JPY 448.13B 173.98B 2025-12
Terumo JPY 69.99B 3.22B 2025-12